Overseas acquisitions: Indian drugmakers shop for deals abroad as they move away from generics

“We are definitely seeing an increase in appetite in terms of overseas deals with the top 10-15 players in the pharma industry,” said Subhakanta Bal, managing director and head of healthcare and consumer (India), Rothschild & Co. “You could say this is an evolution for the Indian pharma sector, where larger companies are increasingly looking at overseas deals.”